Familial hypercholesterolemia and statins in the COVID-19 era: Mitigating the risk of ischemic stroke
There is a continuing need for research about the underlying mechanisms behind ischemic strokes in COVID-19 patients. Pre-existing endothelial dysfunction, especially if it is accompanied by a viral infection of the endothelial cells may present an important mechanism behind the immunothrombotic/thr...
Main Authors: | Alpo Vuorio, Markku Kaste, Petri T. Kovanen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | eNeurologicalSci |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405650221000368 |
Similar Items
-
Patients with familial hypercholesterolemia and COVID-19: Efficient and ongoing cholesterol lowering is paramount for the prevention of acute myocardial infarction
by: Petri T. Kovanen, et al.
Published: (2021-09-01) -
Editorial: Genetics of Familial Hypercholesterolemia: New Insight
by: Alpo Vuorio, et al.
Published: (2021-05-01) -
Decreasing the Cholesterol Burden in Heterozygous Familial Hypercholesterolemia Children by Dietary Plant Stanol Esters
by: Alpo Vuorio, et al.
Published: (2018-12-01) -
Hospitalized Children With Familial Hypercholesterolemia and COVID-19: A Case for Preventive Anticoagulation
by: Alpo Vuorio, et al.
Published: (2021-04-01) -
Preservation of Erectile Function by Statins in a Rat Model of Erectile Dysfunction Induced by Hypercholesterolemia
by: Bong Hee Park, et al.
Published: (2020-03-01)